Jaya Shukla Selected Research

Jaya Shukla Research Topics

Disease

27	Neoplasms (Cancer) 04/2022 - 12/2009
11	Breast Neoplasms (Breast Cancer) 05/2022 - 06/2015
7	Neoplasm Metastasis (Metastasis) 09/2021 - 01/2012
6	Neuroendocrine Tumors (Neuroendocrine Tumor) 09/2020 - 01/2012
4	Pain (Aches) 09/2021 - 06/2007
4	Infertility (Sterility) 07/2021 - 10/2013
4	Paraganglioma (Paragangliomas) 10/2020 - 03/2015
3	Keloid 06/2022 - 09/2017
3	Prostatic Neoplasms (Prostate Cancer) 01/2022 - 10/2018
3	Synovitis 09/2016 - 06/2007
2	Pituitary Neoplasms (Pituitary Adenoma) 10/2021 - 01/2021
2	Cushing Syndrome 10/2021 - 01/2021
2	Pituitary ACTH Hypersecretion 10/2021 - 01/2021
2	Parkinson Disease (Parkinson's Disease) 02/2021 - 04/2018
2	Melanoma (Melanoma, Malignant) 09/2019 - 02/2015
2	Insulinoma 07/2019 - 08/2018
2	Infections 03/2019 - 09/2010
2	Hepatocellular Carcinoma (Hepatoma) 02/2019 - 10/2018
2	Neuroblastoma 01/2017 - 07/2014
2	Oncogenic osteomalacia 01/2015 - 07/2013
1	Lung Neoplasms (Lung Cancer) 09/2021
1	COVID-19 07/2021
1	Chondrosarcoma 06/2021
1	Carcinoma (Carcinomatosis) 04/2021
1	Essential Tremor (Essential Tremors) 02/2021
1	Adenoma (Adenomas) 01/2021
1	Pheochromocytoma 10/2020
1	Carcinoid Tumor (Carcinoid) 09/2020
1	Liver Neoplasms (Liver Cancer) 08/2020
1	Thyroid Neoplasms (Thyroid Cancer) 01/2020
1	Diabetic Foot 03/2019
1	Cellulitis 03/2019
1	Necrosis 02/2019
1	Thrombosis (Thrombus) 02/2019
1	Parathyroid Neoplasms (Parathyroid Neoplasm) 10/2018

Drug/Important Bio-Agent (IBA)

9	Radioisotopes (Radionuclides)IBA 09/2020 - 01/2012
8	RadiopharmaceuticalsIBA 09/2021 - 09/2010
7	1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA 01/2022 - 07/2014
7	Somatostatin Receptors (Somatostatin Receptor)IBA 09/2020 - 01/2012
6	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 01/2022 - 01/2015
5	Tamoxifen FDA LinkGeneric 05/2022 - 12/2009
4	Estrogen ReceptorsIBA 05/2022 - 12/2009
4	Gallium-68IBA 01/2021 - 07/2014
4	IntegrinsIBA 12/2020 - 06/2015
4	Peptide Receptors (Peptide Receptor)IBA 09/2020 - 01/2012
3	aspartic acid glycine arginineIBA 01/2022 - 06/2015
3	arginyl-glycyl-aspartic acidIBA 12/2020 - 08/2019
3	EndotoxinsIBA 03/2019 - 10/2013
3	68Ga-DOTANOCIBA 09/2018 - 02/2015
3	Peptides (Polypeptides)IBA 06/2015 - 04/2012
2	Rhenium-188IBA 06/2022 - 06/2007
2	Trastuzumab (Herceptin)FDA Link 04/2022 - 01/2021
2	Pharmaceutical PreparationsIBA 04/2022 - 06/2016
2	Lutetium-177IBA 01/2022 - 05/2012
2	Adrenocorticotropic Hormone (ACTH)FDA Link 10/2021 - 01/2021
2	Analgesics (Analgesic Drugs)IBA 09/2021 - 09/2010
2	fluorocholineIBA 04/2021 - 10/2018
2	3-Iodobenzylguanidine (Iobenguane)IBA 10/2020 - 01/2016
2	GalliumIBA 09/2019 - 07/2018
2	LigandsIBA 10/2018 - 04/2012
2	AntibodiesIBA 06/2016 - 05/2012
2	Monoclonal AntibodiesIBA 06/2016 - 05/2012
2	Biological ProductsIBA 04/2012 - 01/2012
1	Prostate-Specific Antigen (Semenogelase)IBA 01/2022
1	Docetaxel (Taxotere)FDA Link 01/2022
1	177Lu-PSMA-617IBA 01/2022
1	177Lu- 1,4,7,10- tetraazacyclododecane- 1,4,7,10- tetrakis(methylenephosphonic acid)IBA 09/2021
1	Technetium Tc 99m MedronateIBA 09/2021
1	mesoglycanIBA 07/2021
1	fluorodopa F 18IBA 02/2021
1	Corticotropin-Releasing Hormone Receptors (Corticotropin Releasing-Hormone Receptor)IBA 01/2021
1	tucatinibIBA 01/2021
1	Iodine-131IBA 10/2020
1	CXCR4 Receptors (CXCR4 Receptor)IBA 09/2020
1	Chemokine ReceptorsIBA 09/2020
1	SirtuinsIBA 08/2020
1	Indicators and Reagents (Reagents)IBA 03/2020
1	Estrogen Receptor Modulators (Antiestrogen)IBA 03/2020
1	AcidsIBA 09/2019
1	Germanium-68IBA 09/2019
1	GE 68IBA 09/2019
1	1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA 09/2019
1	Chelating AgentsIBA 09/2019
1	Glucagon-Like Peptide-1 ReceptorIBA 07/2019
1	Glucagon-Like Peptide 1 (GLP 1)IBA 07/2019
1	Dimenhydrinate (DMH)FDA LinkGeneric 05/2019
1	DimethylhydrazinesIBA 05/2019
1	Glutathione (Reduced Glutathione)IBA 05/2019
1	ribosomal protein S30IBA 03/2019
1	1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA 03/2019

Therapy/Procedure

17	Therapeutics 01/2021 - 06/2007
3	Drug Therapy (Chemotherapy) 01/2022 - 01/2012
3	Precision Medicine 07/2021 - 01/2020
3	Microspheres (Microsphere) 08/2020 - 09/2018
2	Neoadjuvant Therapy 01/2022 - 08/2019
2	Palliative Care (Palliative Therapy) 09/2021 - 01/2017
2	Intravenous Administration 07/2021 - 06/2016
2	Radiotherapy 06/2021 - 09/2017
1	Castration 01/2022
1	Subcutaneous Injections 05/2019